Bondoc si Asociatii, on the side of Alvogen in connection with the sale of its CEE business to Zentiva group

Zentiva Group a.s. confirms the closing of its previously declared acquisition of Alvogen’s Central and Eastern European (CEE) business.

The deal adds to Zentiva’s continuing organic growth, reinforcing Zentiva’s commercial footprint in Poland, Romania and Bulgaria, and expanding its presence into additional new markets including Russia, Ukraine, Kazakhstan, Hungary, Croatia and West Balkans.

As a result, Zentiva can now deliver an expanded product portfolio to millions more people across Europe and beyond.

“Bondoc si Asociatii has assisted Alvogen trough a multidisciplinary team on Romanian law issues with respect to the sale of its CEE business to Zentiva group. This project further confirms the strength of the Firm in M&A, as well as its leading experience in the healthcare sector”, the law firm told ^BizLawyer.

Alongside the recently announced acquisition of the manufacturing site in Ankleshwar, expected to be finalized in the coming weeks, this acquisition also expands Zentiva’s production capacity with the Labormed Alvogen site in Bucharest, Romania.